About
Yseop is a regulatory-grade AI platform designed specifically for pharmaceutical companies, biotech firms, and contract research organizations. Unlike general-purpose AI writing tools, Yseop produces submission-ready documents with the accuracy, traceability, and control required by health authorities worldwide. Powered by neuro-symbolic AI, Yseop validates every output against regulatory rules and templates, grounding all content in source data rather than generated assumptions. Every sentence is linked to its source from the outset, providing a complete audit trail ready for inspection. GSK production studies show less than 7% of content requires re-authoring after AI generation. Yseop integrates directly into Microsoft Word and connects with Veeva Vault and existing regulatory infrastructure, so teams can adopt it without learning a new system. It supports locking, reusing, and scaling approved content across documents and submissions — update once and propagate everywhere without breaking approved sections. Key capabilities include patient narrative generation (reduced from 4+ hours to 4 seconds at Lilly), CTD regulatory report automation, and cross-submission consistency. The platform operates on the principle that AI executes while humans decide — every output must be validated, traceable, and approved by the regulatory team before moving forward. Yseop is a TIME Best Invention of 2025 and a two-time BIG Innovation Award winner.
Key Features
- Submission-Ready Document Generation: Automates regulatory report documents across the CTD pyramid, validated against regulatory rules and templates with less than 7% of content requiring re-authoring in production.
- Full Source Traceability: Every sentence is linked to its source data from creation, providing a complete audit trail ready for health authority inspection at any time.
- Microsoft Word & Veeva Vault Integration: Works directly inside Microsoft Word and integrates with Veeva Vault so teams can adopt it without disrupting existing regulatory workflows or learning new systems.
- Repeatable, Consistent Output: Delivers consistent content across documents, teams, and submissions. Update approved content once and propagate changes everywhere without breaking locked sections.
- Human-in-the-Loop Validation: Every AI-generated output must be reviewed and approved by the team before moving forward — AI executes, humans decide, ensuring regulatory accountability.
Use Cases
- Automating patient narrative generation for clinical study reports, reducing authoring time from 4+ hours to 4 seconds per narrative
- Generating submission-ready CTD regulatory documents with full source traceability for health authority review
- Maintaining cross-submission consistency by locking and reusing approved content across multiple regulatory filings
- Accelerating drug and vaccine market entry timelines by eliminating regulatory writing bottlenecks worth $1–3M per day
- Scaling medical writing output at large pharmaceutical companies without proportionally increasing headcount
Pros
- Dramatically Accelerates Submission Timelines: Patient narratives that once took 4+ hours can be generated in 4 seconds, and CTD document automation significantly shortens regulatory submission timelines.
- Regulatory-Grade Accuracy: Less than 7% of content requires re-authoring in GSK production studies, with all output grounded in source data rather than AI hallucination.
- Seamless Enterprise Integration: Native compatibility with Microsoft Word and Veeva Vault ensures minimal disruption to established medical writing and regulatory workflows.
- Industry-Recognized Credibility: Named TIME's Best Invention of 2025 and a two-time BIG Innovation Award winner, with deployments at top-tier pharma companies including Lilly, Sanofi, and GSK.
Cons
- Enterprise-Only Pricing: Yseop is positioned as an enterprise solution with no self-serve or free tier, making it inaccessible to smaller organizations or individual researchers.
- Life Sciences Use Case Only: The platform is purpose-built for pharmaceutical and regulatory submissions — it is not a general-purpose writing or document automation tool.
- Integration Overhead: Realizing full value requires integration with existing data systems and Veeva Vault, which may involve significant implementation time and IT coordination.
Frequently Asked Questions
What makes Yseop different from general AI writing tools?
Unlike general AI tools, Yseop produces regulatory submission-ready content grounded in source data with full traceability from every sentence back to its source. It validates output against regulatory rules and templates and maintains a complete audit trail — capabilities general-purpose AI tools cannot provide.
What types of documents can Yseop automate?
Yseop automates core regulatory report documents across the CTD pyramid, including clinical study reports, patient narratives, and other medical writing deliverables required for regulatory submissions to health authorities worldwide.
How does Yseop integrate with existing regulatory workflows?
Yseop works directly inside Microsoft Word so no new system needs to be learned. It also integrates with Veeva Vault and other existing regulatory infrastructure, allowing teams to adopt it with minimal process disruption.
Is human oversight required when using Yseop?
Yes — Yseop is built on the principle that 'AI executes, humans decide.' Every AI-generated output must be reviewed, validated, and approved by your team before it moves forward. Accountability in regulatory submissions cannot be automated.
What AI technology powers Yseop?
Yseop uses neuro-symbolic AI, which combines neural network capabilities with symbolic reasoning to achieve the regulatory-grade reliability required for pharmaceutical submissions. This architectural approach enables traceable, auditable, and consistently accurate output at scale.
